Woodline Partners’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.4M | Sell |
629,357
-135,000
| -18% | -$3.51M | 0.09% | 326 |
|
|
2025
Q1 | $18.7M | Buy |
764,357
+135,472
| +22% | +$3.32M | 0.12% | 240 |
|
|
2024
Q4 | $18M | Buy |
628,885
+22,987
| +4% | +$659K | 0.12% | 228 |
|
|
2024
Q3 | $22.9M | Buy |
605,898
+80,699
| +15% | +$3.04M | 0.19% | 173 |
|
|
2024
Q2 | $16.6M | Hold |
525,199
| – | – | 0.16% | 191 |
|
|
2024
Q1 | $23.1M | Buy |
+525,199
| New | +$23.1M | 0.21% | 146 |
|